Patents by Inventor Alejandro Felipe Escobar Álvarez

Alejandro Felipe Escobar Álvarez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250090728
    Abstract: The invention provides a silicone material functionalized with PEG-coated (PEGylated) copper nanoparticles that reduces bacterial load and biofilm formation. The material in accordance with the invention may be used in the manufacture of devices or products for use in the clinical and/or biomedical industry, food or any other industry where antibacterial and antibiofilm properties are desirable and necessary.
    Type: Application
    Filed: December 9, 2022
    Publication date: March 20, 2025
    Inventors: María Cristina PAREDES ESCOBAR, David Arturo MONTERO FORERO, Alejandro Felipe ESCOBAR ÁLVAREZ, Gabriel Nelson ABARCA ANJARÍ
  • Patent number: 9694059
    Abstract: The present invention relates to an ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases. At the same time, it is related to a cellular composition that contributes to stimulate the activated antigen-presenting cells to induce a specific immune response against tumors in patients with cancer or other pathologies involving immune responses.
    Type: Grant
    Filed: May 1, 2013
    Date of Patent: July 4, 2017
    Assignee: Universidad de Chile
    Inventors: Flavio Andres Salazar Onfray, Mercedes Natalia Lopez Nitsche, Cristian Javier Pereda Ramos, Raquel Elvira Aguilera Insunza, Alejandro Felipe Escobar Alvarez
  • Publication number: 20100303868
    Abstract: The present invention relates to an ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases. At the same time, it is related to a cellular composition that contributes to stimulate the activated antigen-presenting cells to induce a specific immune response against tumors in patients with cancer or other pathologies involving immune responses.
    Type: Application
    Filed: September 26, 2008
    Publication date: December 2, 2010
    Applicants: UNIVERSIDAD DE CHILE, ONCOBIOMED
    Inventors: Flavio Andrés Salazar Onfray, Mercedes Natalia López Nitsche, Cristián Javier Pereda Ramos, Raquel Elvira Aguilera Insunza, Alejandro Felipe Escobar Álvarez